Post-menopausal Bleeding

Introduction

Post-menopausal bleeding is any vaginal bleeding that happens twelve months or more after your last menstrual period. Even a small amount of spotting counts. If you have noticed bleeding after menopause and are now planning the next step, this article explains what may be causing it, what tests doctors typically use to investigate, and what treatments are available depending on what is found.

The most important thing to know is this: most causes of post-menopausal bleeding (sometimes shortened to PMB) are not cancer. Thinning of the vaginal and uterine lining, polyps, and hormone therapy effects are far more common explanations. However, because endometrial cancer — cancer of the lining of the uterus — is one of the possible causes, every episode of bleeding after menopause needs proper medical evaluation. The aim of the work-up is to either find a treatable benign cause or catch cancer at an early stage, when it is highly treatable.

This article walks through what counts as post-menopausal bleeding, the range of possible causes, how doctors investigate it, treatment options for each cause, and what to expect afterwards.

What Is Post-menopausal Bleeding?

Menopause is the point in a woman’s life when periods stop permanently. It is diagnosed retrospectively, after twelve consecutive months without a menstrual period. The average age of menopause is around 51, though it can happen earlier or later. Any vaginal bleeding that happens after that twelve-month mark is called post-menopausal bleeding.

This includes:

• Light spotting or a few drops of blood on underwear or toilet paper
• Pink, brown, or red discharge
• A single episode of bleeding, even if it does not happen again
• Heavier bleeding similar to a period
• Bleeding after sexual intercourse

The amount of bleeding does not reliably indicate the seriousness of the cause. A small amount of spotting can sometimes be the first sign of a significant problem, while heavier bleeding can come from a benign cause such as a polyp. This is why the rule is consistent across major professional guidelines: any bleeding after menopause should be evaluated by a doctor, regardless of amount.

If you are taking hormone replacement therapy (HRT), the rules are slightly different and are discussed in the causes section below.

Causes of Post-menopausal Bleeding

Endometrial and vaginal atrophy

This is the most common cause of post-menopausal bleeding. After menopause, oestrogen levels fall, and the tissues lining the vagina and the uterus become thinner, drier, and more fragile. Thin tissues can bleed with minor friction — from intercourse, from a pelvic examination, or even spontaneously. Atrophy accounts for a large share of post-menopausal bleeding cases.

Endometrial or cervical polyps

Polyps are small, usually benign growths that develop from the lining of the uterus (endometrial polyps) or the cervix (cervical polyps). They can bleed intermittently. Most polyps are not cancerous, but a small proportion can contain abnormal or pre-cancerous cells, which is why doctors typically recommend removing them and examining them under a microscope.

Endometrial hyperplasia

Endometrial hyperplasia means the lining of the uterus has become thicker than normal. This can happen when the lining is exposed to oestrogen without enough progesterone to balance it. The current FIGO classification divides hyperplasia into two types: hyperplasia without atypia (lower risk of progressing to cancer) and atypical hyperplasia (significantly higher risk). The treatment approach differs sharply between the two, which is why a tissue sample is important.

Endometrial cancer

Cancer of the lining of the uterus is the cause that drives the entire approach to investigating post-menopausal bleeding. Major societies including ACOG, RCOG, and NICE all describe post-menopausal bleeding as the most common presenting symptom of endometrial cancer. Across studies, roughly one in ten women presenting with post-menopausal bleeding turn out to have endometrial cancer, though the exact proportion varies with age and risk factors. The good news is that because bleeding appears early in the disease, endometrial cancer is often diagnosed at an early stage, when outcomes are very good.

Cervical cancer and other gynaecological cancers

Less commonly, post-menopausal bleeding can be caused by cervical cancer, vaginal cancer, or other cancers of the reproductive tract. These also need to be considered during evaluation.

Hormone replacement therapy (HRT)

Some women on hormone replacement therapy experience bleeding. The significance depends on the type of HRT and the timing:

• On cyclical (sequential) HRT, scheduled monthly withdrawal bleeding is expected and is not considered post-menopausal bleeding in the concerning sense. However, bleeding that is heavier than expected, at the wrong time in the cycle, or breakthrough bleeding still needs evaluation.
• On continuous combined HRT, some irregular bleeding is common in the first three to six months. Bleeding that continues beyond six months, or new bleeding after a period of no bleeding, should be investigated.

Tamoxifen and certain medications

Tamoxifen, a medication used in the treatment of some breast cancers, can stimulate the endometrium and is associated with an increased risk of endometrial changes, including polyps, hyperplasia, and cancer. Women taking tamoxifen who experience any bleeding need prompt evaluation. Blood-thinning medications can sometimes contribute to bleeding from already fragile tissues.

Infections and other causes

Less common causes include infections of the cervix or uterus, trauma to the vaginal tissue, and bleeding from non-gynaecological sources such as the urinary tract or rectum that can be mistaken for vaginal bleeding.

Risk Factors for the More Serious Causes

Some factors increase the likelihood that post-menopausal bleeding has a more serious underlying cause, particularly endometrial hyperplasia or cancer. These do not change the fact that everyone with PMB needs evaluation, but they help doctors decide on the urgency and depth of investigation.

• Age — the risk of endometrial cancer rises with age
• Obesity — fatty tissue produces oestrogen, increasing exposure of the endometrium
• Diabetes and metabolic syndrome
• Polycystic ovary syndrome (PCOS) in the reproductive years
• Never having been pregnant
• Late menopause (after age 55)
• Tamoxifen use
• Oestrogen-only HRT in a woman with a uterus (this is generally avoided for this reason)
• Family history of endometrial, ovarian, or colon cancer, particularly Lynch syndrome

Diagnosis: How Post-menopausal Bleeding Is Investigated

The aim of the work-up is to either identify a benign, treatable cause or to detect a more serious cause early. Modern guidelines describe a stepwise approach, starting with history, examination, and ultrasound, and proceeding to tissue sampling when indicated.

Medical history and examination

Your doctor will ask about the timing and amount of bleeding, when your menopause occurred, any HRT or other medications, your gynaecological history, and risk factors. A pelvic examination follows, including inspection of the vulva, vagina, and cervix to look for visible sources of bleeding such as atrophic changes, polyps, or cervical lesions. A cervical screening (Pap) test is often performed if you are due or if there is any cervical abnormality.

Transvaginal ultrasound (TVS)

Major societies including ACOG and RCOG describe specific thickness thresholds:

• An endometrial thickness of 4 mm or less in a woman with post-menopausal bleeding is generally considered reassuring and is associated with a very low risk of endometrial cancer. In this situation, further investigation may not be needed immediately if the bleeding settles, though follow-up is required if bleeding continues or recurs.
• An endometrial thickness greater than 4 mm, or a thickened lining that cannot be measured clearly, generally leads to further investigation with tissue sampling.

Ultrasound can also identify polyps, fibroids, ovarian cysts, and fluid in the uterine cavity, each of which influences next steps.

Endometrial biopsy

An endometrial biopsy means taking a small sample of tissue from the lining of the uterus to examine under the microscope. The most common technique is an outpatient procedure using a thin, flexible plastic tube (often called a pipelle) passed through the cervix. The procedure usually takes a few minutes. Most women experience some cramping similar to a period, which settles within a short time.

The biopsy can identify atrophy, polyps (sometimes), hyperplasia (with or without atypia), and cancer. It is generally a reliable test, though sometimes the sample is insufficient or non-diagnostic, in which case further investigation is needed.

Hysteroscopy

Hysteroscopy is a procedure in which a thin telescope with a camera is passed through the cervix to look directly inside the uterine cavity. It can be performed in the outpatient clinic (often called “office” or “outpatient” hysteroscopy) without general anaesthesia, or in an operating theatre under general anaesthesia (often combined with dilatation and curettage, or D&C).

Hysteroscopy allows the doctor to:

• See polyps, fibroids, and other abnormalities directly
• Take targeted biopsies from suspicious areas
• Remove polyps at the same time

It is often used when ultrasound suggests a focal lesion such as a polyp, when an outpatient biopsy is inconclusive, or when bleeding continues despite a normal initial work-up.

Saline infusion sonography

This is an ultrasound performed with a small amount of sterile saline introduced into the uterine cavity. The fluid separates the uterine walls and gives a clearer view, especially of polyps or focal thickening of the endometrium. It is used in some centres as an additional tool.

MRI and further imaging

If cancer is suspected or confirmed, MRI of the pelvis is often used to assess the extent of disease and to help plan treatment. CT scans and other imaging may be added depending on the findings.

Treatment Based on the Underlying Cause

Treatment of post-menopausal bleeding depends entirely on what the investigations show. The bleeding itself is a symptom; what is treated is the underlying cause.

Treatment for atrophic changes

If vaginal or endometrial atrophy is the cause, treatment is often straightforward. Options that doctors commonly discuss include:

• Topical (vaginal) oestrogen in the form of creams, tablets, or rings. These deliver a small amount of oestrogen directly to the vaginal tissues and have very low absorption into the rest of the body. They typically improve dryness, fragility, and atrophic bleeding within a few weeks.
• Non-hormonal vaginal moisturisers and lubricants, which can ease symptoms for women who prefer to avoid or cannot take hormonal treatment.
• Systemic HRT, where it is appropriate for other reasons, can also help with atrophy.

Whether a particular treatment is appropriate depends on your overall health, breast cancer history, and other factors that you and your doctor will discuss.

Treatment for polyps

Endometrial and cervical polyps are usually removed, both to stop the bleeding and to examine the tissue for any abnormal cells. Removal techniques include:

• Hysteroscopic polypectomy — removal during hysteroscopy. This is the standard method for endometrial polyps and can often be done as a day-case procedure.
• Outpatient removal for some visible cervical polyps, which can often be removed in clinic with simple instruments.

The removed tissue is sent for pathology examination. The large majority of polyps are benign.

Treatment for endometrial hyperplasia

Treatment of endometrial hyperplasia depends on whether there is atypia (abnormal-looking cells under the microscope).

Hyperplasia without atypia has a low risk of progressing to cancer. Doctors commonly treat it with progestogen therapy, either as oral tablets or, more often, as a hormone-releasing intrauterine system (IUS) placed inside the uterus. The IUS delivers progestogen directly to the endometrium and is described by RCOG as a first-line option for many women. Follow-up biopsies are arranged to confirm that the hyperplasia has resolved.

Atypical hyperplasia carries a higher risk of progressing to, or co-existing with, endometrial cancer. Major societies including RCOG and ACOG describe hysterectomy (removal of the uterus) as the treatment doctors typically recommend for post-menopausal women with atypical hyperplasia. In selected cases — for example, where surgery carries a high risk — progestogen-based treatment with close monitoring may be considered.

Treatment for endometrial cancer

If endometrial cancer is diagnosed, treatment is planned by a gynaecological cancer team and depends on the stage and type of cancer. The main treatments include:

• Surgery — usually a total hysterectomy with removal of the fallopian tubes and ovaries (bilateral salpingo-oophorectomy), often with assessment of nearby lymph nodes. This is the cornerstone of treatment for most endometrial cancers and is increasingly performed using minimally invasive (laparoscopic or robotic) approaches.
• Radiotherapy — used after surgery in some cases to reduce the risk of recurrence, or as a main treatment for women who are not suitable for surgery.
• Chemotherapy — used for more advanced or higher-risk cancers, often combined with surgery and radiotherapy.
• Hormonal and targeted therapies — used in selected situations, particularly for advanced or recurrent disease.

Because bleeding often brings women to medical attention early, many endometrial cancers are diagnosed at an early stage, where surgery alone is often sufficient and outcomes are very favourable.

Treatment for cervical and other cancers

If a cervical or other gynaecological cancer is identified, treatment is planned by the relevant specialist team and may include surgery, radiotherapy, chemotherapy, or a combination, depending on the type and stage.

Adjusting hormone replacement therapy

If HRT is the most likely cause of bleeding and serious causes have been excluded, doctors may adjust the type, dose, or schedule of HRT. This is a clinical decision based on the bleeding pattern, the reason HRT is being used, and your preferences.

What If No Cause Is Found?

Sometimes a thorough work-up — ultrasound, biopsy, and possibly hysteroscopy — finds no specific cause for the bleeding. In this situation, the most common underlying explanation is mild atrophic change that is not always visible on tests.

If no cause is found and the bleeding settles, doctors typically arrange follow-up rather than further immediate testing. However, if bleeding recurs, even after a clear initial work-up, the evaluation should be repeated. Recurrent post-menopausal bleeding always warrants re-evaluation rather than reassurance.

After Diagnosis and Treatment

The experience after evaluation depends on what is found and what treatment is given.

If the cause is benign

For most women, the cause is benign and treatment is relatively simple. Bleeding from atrophy often improves within weeks of starting topical treatment. Polyp removal is a day-case procedure with a short recovery. Most women return to normal activities quickly. Follow-up is usually limited but the rule remains: any new bleeding in the future should prompt fresh evaluation, not be assumed to be the same cause as before.

If hyperplasia is diagnosed

Women treated with progestogen therapy for hyperplasia typically have follow-up biopsies, often at three to six month intervals, to confirm that the lining has returned to normal. Once stable, longer-term monitoring continues for a period of time guided by current guidelines and individual risk.

If cancer is diagnosed

If endometrial or another cancer is diagnosed, you will be referred to a specialist gynaecological oncology team. Treatment planning involves staging investigations, discussion in a multidisciplinary meeting, and a conversation about the options. Recovery from surgery for early-stage endometrial cancer is generally good. After treatment, you will be followed up regularly to watch for recurrence; the schedule depends on the stage and treatment given.

When to Seek Urgent Care

Post-menopausal bleeding is generally not an emergency, but the evaluation should not be delayed. Major societies describe post-menopausal bleeding as a symptom that needs prompt — though not same-day — assessment, typically within a few weeks at most. NICE guidance in the UK, for example, recommends urgent referral for any woman over 55 with post-menopausal bleeding.

Seek more urgent medical attention if:

• Bleeding is very heavy (soaking through a pad an hour for more than two hours)
• You feel faint, dizzy, or unwell with the bleeding
• Bleeding is accompanied by severe pelvic pain
• There are signs of infection such as fever or foul-smelling discharge

Otherwise, the standard pathway is to contact your doctor or gynaecologist promptly and arrange evaluation within the next few weeks.

Frequently Asked Questions

I only had spotting once. Do I still need to see a doctor?

Yes. The amount of bleeding does not predict the cause. Even a single episode of light spotting after menopause should be evaluated. Most often the cause is benign, but a single check protects against missing something more serious.

Could it just be from intercourse?

Bleeding after intercourse in a post-menopausal woman is commonly caused by vaginal atrophy — the thin, fragile tissue tears easily. However, it can also be a sign of cervical or vaginal problems, including cancer in some cases. Bleeding after intercourse still needs evaluation.

Does endometrial cancer always cause heavy bleeding?

No. Endometrial cancer often presents with very light bleeding or spotting, sometimes just once or twice. This is one reason every episode of post-menopausal bleeding is taken seriously, regardless of how heavy it is.

I’m on HRT and bleeding. Is that normal?

It depends on the type of HRT and how long you have been on it. Some bleeding is expected on cyclical HRT and in the first few months of continuous combined HRT. Bleeding outside these expected patterns, or that continues beyond the early months, should be investigated. Your doctor will look at the pattern and decide whether further tests are needed.

How accurate is the endometrial thickness measurement?

Transvaginal ultrasound is a good first test but is not perfect. A thin endometrial measurement is generally reassuring, but if bleeding continues or recurs, further investigation is needed even if the initial scan looked normal. A thickened endometrium does not mean cancer — it means more information is needed, usually with a biopsy.

Is the endometrial biopsy painful?

Most women describe cramping similar to period pain during the procedure, lasting a few minutes. Some find it more uncomfortable, others less. Pain relief such as paracetamol or ibuprofen taken before the appointment can help. If the procedure cannot be completed in the outpatient setting, or if the cervix is difficult to access, it can be done under general anaesthesia along with a hysteroscopy.

Can post-menopausal bleeding come back after treatment?

Yes, depending on the cause. Atrophic bleeding can recur if topical treatment is stopped. New polyps can develop. Any new episode of bleeding after menopause — even after a previous evaluation found a benign cause — should be evaluated again. It cannot be assumed to be the same problem.

If a hysterectomy is recommended, will I need my ovaries removed too?

That depends on why the hysterectomy is being done and your individual situation. For atypical hyperplasia or endometrial cancer, removal of the fallopian tubes and ovaries (bilateral salpingo-oophorectomy) is often part of the surgery in post-menopausal women, because the ovaries are no longer producing significant hormones and there is a small risk of ovarian involvement. Your surgeon will discuss the specifics with you before the operation.

Does post-menopausal bleeding always mean cancer?

No. Most causes of post-menopausal bleeding are benign — atrophy and polyps account for the majority of cases. However, because endometrial cancer is one possible cause, and because it is highly treatable when caught early, every episode is investigated to rule it out.

Conclusion

Post-menopausal bleeding can be alarming, but the framework for handling it is well-established and reassuring in most cases. The principle that guides every major guideline is the same: investigate every episode, treat the underlying cause, and use the bleeding as an opportunity to detect any serious problem at an early stage. Most women will be found to have a benign and treatable cause, and even when a more serious diagnosis is made, early detection significantly improves outcomes.

The next step, once you have noticed bleeding after menopause, is a clinical evaluation with a gynaecologist. The diagnosis and treatment plan that follow will be shaped by the findings of that evaluation and by a discussion with your doctor about the options that fit your situation.